-0.07 | -3.85%
| Price and Volume | |
|---|---|
| Recent Price | 1.82 |
| 52 Week High | 2.47 |
| 52 Week Low | 1.51 |
| Avg. Daily Vol. (Mil) | 0.02 |
| Beta (3 year) | 0.49 |
| Share Related Items | |
| Mkt Cap (Mil) | 37.62 |
| Shares Out (Mil) | 20.67 |
| Float (Mil) | 17.44 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.00 |
| Current Ratio | 5.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.01 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.68 |
| Price/Book | 1.98 |
| Price/Cash Flow | 112.00 |
| Per Share Data | |
| Earnings | -0.03 |
| Sales | 1.08 |
| Book Value | 0.92 |
| Cash Flow | 0.02 |
| Business Summary | |
|---|---|
| Strategic Diagnostics Inc. is a Delaware corporation formed in 1990. It is a biotechnology company which operates in two areas, Life Sciences and Kit Products. | |
| General Information | |
| 111 Pencader Drive
Newark, DE 19702 |
|
| www.sdix.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 143 | |
| CEO: Francis M. DiNuzzo | |
| Short Interest | |
| Current Month (Mil) | 0.01 |
| Previous Month (Mil) | 0.01 |
| Short Interest Ratio (Days) | 0.50 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -3.80 |
| Return on Investments | -4.40 |
| Profitability | |
| Gross Margin | 61.40 |
| EBIT Margin | -23.50 |
| Profit Margin | -3.70 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,436.02 | 1,315.61 | 2,840.16 | 16.25 |
Oil *
103.16
|
|
DOWN
144.67 |
DOWN
16.81 |
DOWN
30.83 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.90
|
|
-1.15%
|
-1.26%
|
-1.07%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet